ES2061603T3 - Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos. - Google Patents
Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos.Info
- Publication number
- ES2061603T3 ES2061603T3 ES88118266T ES88118266T ES2061603T3 ES 2061603 T3 ES2061603 T3 ES 2061603T3 ES 88118266 T ES88118266 T ES 88118266T ES 88118266 T ES88118266 T ES 88118266T ES 2061603 T3 ES2061603 T3 ES 2061603T3
- Authority
- ES
- Spain
- Prior art keywords
- same
- methods
- vaccines
- infectious bovine
- contain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 230000003612 virological effect Effects 0.000 title abstract 2
- 208000005562 infectious bovine rhinotracheitis Diseases 0.000 title 1
- 241000283690 Bos taurus Species 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 230000002458 infectious effect Effects 0.000 abstract 2
- 230000035772 mutation Effects 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
MUTACIONES DEL VIRUS(HERPERVIRUS VACUNO TIPO 1) DE SINOTRAGUITIS BOVINA INFECCIOSA CONTENIENDO MUTACIONES POR SUPRESION Y/O INSERCCION, TAL QUE LOS POLIPECTIDOS NO ANTIGENICOS CODIFICADOS POR EL GRAN VIRILO SON PRODUCIDOS, VACUNAS PARA LA SINOTRAQUITIS BOVINA INFECCIOSA, METODOS PARA LA PRODUCCION DE LAS MISMAS Y METODOS DE USO DE LAS MISMAS. LOS ANIMALES VACUNADOS CON ESTOS MONTANTES NO DESARROLLAN ANTICUERPOS A LA GLICOPROTEINA VIRICA Y PUEDEN SER DISTINGUIDOS SEROLOGICAMENTE DE LOS ANIMALES INFECTADOS CON EL MISMO DE LA SINOFRAGUETIS BOVINA INFECCIOSA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/116,197 US4992051A (en) | 1987-11-03 | 1987-11-03 | Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2061603T3 true ES2061603T3 (es) | 1994-12-16 |
Family
ID=22365852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88118266T Expired - Lifetime ES2061603T3 (es) | 1987-11-03 | 1988-11-02 | Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4992051A (es) |
EP (1) | EP0316658B1 (es) |
JP (1) | JPH02431A (es) |
AT (1) | ATE102650T1 (es) |
AU (1) | AU2403188A (es) |
CA (1) | CA1299121C (es) |
DE (1) | DE3888290T2 (es) |
ES (1) | ES2061603T3 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593873A (en) * | 1986-01-27 | 1997-01-14 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
US6410033B1 (en) | 1987-07-27 | 2002-06-25 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
AU2888089A (en) * | 1988-01-26 | 1989-07-27 | Baylor College Of Medicine | Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production and use of same |
FR2693472B1 (fr) * | 1992-06-26 | 1994-12-23 | Rhone Merieux | Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation. |
FR2659349B1 (fr) | 1990-03-12 | 1993-12-24 | Rhone Merieux | Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus. |
NL9100989A (nl) * | 1991-06-07 | 1993-01-04 | Stichting Centr Diergeneeskund | Bovine herpesvirus type 1 deletiemutanten, daarop gebaseerde vaccins, diagnostische kits voor detectie van bovine herpesvirus type 1. |
CA2113641A1 (en) * | 1991-07-18 | 1993-02-04 | Mark D. Cochran | Recombinant infectious bovine rhinotracheitis virus |
DE4141400A1 (de) * | 1991-12-16 | 1993-06-17 | Bayer Ag | Impfstoffe auf basis geaenderter boviner herpesviren typ 1 |
EP0738319A4 (en) * | 1994-01-12 | 2000-03-29 | Genetic Therapy Inc | Purification of retroviral vectors |
JP4432516B2 (ja) * | 2004-02-06 | 2010-03-17 | 日産自動車株式会社 | 車体前部構造 |
AR084358A1 (es) * | 2010-12-27 | 2013-05-08 | Lilly Co Eli | Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc)) |
CN102653731A (zh) * | 2011-03-02 | 2012-09-05 | 华中农业大学 | 一种缺失gG,TK和gE基因的重组牛传染性鼻气管炎病毒 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0074808A3 (en) * | 1981-09-16 | 1984-07-04 | University Patents, Inc. | Recombinant method and materials |
CA1237668A (en) * | 1983-02-25 | 1988-06-07 | Novagene Inc. | Thymidine kinase-negative temperature resistant bovine herpes-virus-1 mutant as vaccine |
ATE60799T1 (de) * | 1985-07-29 | 1991-02-15 | Upjohn Co | Virus-impfstoff. |
US4703011A (en) * | 1985-11-12 | 1987-10-27 | Novagene, Inc. | Thymidine kinase deletion mutants of bovine herpesvirus-1 |
AU623333B2 (en) * | 1986-01-27 | 1992-05-14 | Syntro Corporation | Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
US4711850A (en) * | 1986-01-28 | 1987-12-08 | Novagene, Inc. | Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
-
1987
- 1987-11-03 US US07/116,197 patent/US4992051A/en not_active Expired - Fee Related
-
1988
- 1988-09-30 CA CA000579000A patent/CA1299121C/en not_active Expired - Lifetime
- 1988-10-19 AU AU24031/88A patent/AU2403188A/en not_active Abandoned
- 1988-11-02 AT AT88118266T patent/ATE102650T1/de not_active IP Right Cessation
- 1988-11-02 ES ES88118266T patent/ES2061603T3/es not_active Expired - Lifetime
- 1988-11-02 EP EP88118266A patent/EP0316658B1/en not_active Expired - Lifetime
- 1988-11-02 DE DE3888290T patent/DE3888290T2/de not_active Expired - Fee Related
- 1988-11-03 JP JP63278495A patent/JPH02431A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE3888290T2 (de) | 1994-08-11 |
DE3888290D1 (de) | 1994-04-14 |
ATE102650T1 (de) | 1994-03-15 |
CA1299121C (en) | 1992-04-21 |
JPH02431A (ja) | 1990-01-05 |
EP0316658A1 (en) | 1989-05-24 |
AU2403188A (en) | 1989-06-01 |
EP0316658B1 (en) | 1994-03-09 |
US4992051A (en) | 1991-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2188583T3 (es) | Polipeptidos para el virus de la hepatitis c (hcv). | |
ES2061500T5 (es) | Diagnosis y vacunas de la hepatitis delta, su preparacion y uso. | |
MY103182A (en) | Vaccines against acquired immune deficiency syndrome. | |
IL89701A0 (en) | Recombinant retroviruses,method for the production thereof and pharmaceutical composition containing the same | |
ES2061603T3 (es) | Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos. | |
ATE295895T1 (de) | Genetischer impfstoff gegen den immunschwäche virus | |
MX9203458A (es) | Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano. | |
DE69333397D1 (de) | Retro-, inverso-, und retro-inverso synthetische peptidanaloge | |
GR3019112T3 (en) | Porcine reproductive respiratory syndrome vaccine and diagnostic. | |
ES2143507T3 (es) | Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia. | |
ES8500997A1 (es) | Un metodo para producir un peptido. | |
ES2035818T3 (es) | Mutantes de delecion de la timidin-kinasa del virus del herpes bovino-1, vacunas contra la rinotraqueitis bovina infecciosa que los contienen y metodos para su produccion y uso. | |
ATE19591T1 (de) | Virus der infektioesen katzen-bauchfellentzuendung, seine herstellung und es enthaltende vakzine. | |
AR021414A1 (es) | Formulaciones conteniendo particulas semejantes a virus como inmunopotenciadores por via mucosal | |
AR248046A1 (es) | Biosintesis de una secuencia de adn codificante de una glicoproteina inmunogena de hospedantes de garrapatas, sonda de hibridizacion, moleculas de dna, transformantes y plasmidos. | |
IL86675A (en) | Immunogen containing non- infectious hiv particles and pharmaceutical compositions containing the same | |
NZ228232A (en) | Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry | |
ES2055610T3 (es) | Vacuna contra hrsv. | |
ES2074965B1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
MX9303771A (es) | Proteina viral icp27 del virus vhs-2, proceso para su preparacion y composicion de vacuna que la incluye. | |
ATE205220T1 (de) | Hepatitis-a-impfstoff | |
ES2055687T3 (es) | Vacuna de virus. | |
FI902814A0 (fi) | Proteiner, vaccin och nukleinsyror. | |
ES2084587T3 (es) | Arn virus no revertientes. | |
CA652677A (en) | Vaccine preparation from attenuated infectious canine hepatitis virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 316658 Country of ref document: ES |